Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Status

Therapeutic Category

Polymorphic form

CAS No.

    A
  • Acenocumarol

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic form

    CAS No.152-72-7

    View more
  • Acetazolamide

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm II

    CAS No. 59-66-5

    View more
  • C
  • Carvedilol

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm II

    CAS No.72956-09-3

    View more
  • Carvedilol phosphate hemihydrate

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm I

    CAS No.610309-89-2

    View more
  • Clopamide

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formPolymorphic form

    CAS No.636-54-4

    View more
  • H
  • Hydrochlorothiazide

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm I

    CAS No.58-93-5

    View more
  • M
  • Molsidomine

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic form

    CAS No.25717-80-0

    View more
  • P
  • Pentoxifylline

    StatusCommercial

    Therapeutic CategoryCardiovascular system

    Polymorphic formForm I

    CAS No.1677687

    View more